These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7316178)

  • 1. A method for rapid quantitation and preparation of antithrombin III--high-affinity heparin fractions.
    Takahashi HK; Nader HB; Dietrich CP
    Anal Biochem; 1981 Sep; 116(2):456-61. PubMed ID: 7316178
    [No Abstract]   [Full Text] [Related]  

  • 2. Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.
    Horner AA; Young E
    J Biol Chem; 1982 Aug; 257(15):8749-54. PubMed ID: 7096332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.
    Edens RE; Fromm JR; Fromm SJ; Linhardt RJ; Weiler JM
    Biochemistry; 1995 Feb; 34(8):2400-7. PubMed ID: 7873519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of inhibitors and the mechanisms of action of antithrombin III.
    Rosenberg RD; Oosta GM
    Prog Clin Biol Res; 1981; 72():179-203. PubMed ID: 7335648
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weight.
    Ekre HP
    Int J Immunopharmacol; 1985; 7(2):271-80. PubMed ID: 4008141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between heparin and antithrombin III: a comparison of two different heparin-dye conjugates.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1987 Jul; 925(1):57-62. PubMed ID: 3109497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
    Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
    Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of protein-bound heparin and antithrombin III.
    Shanberge JN; Sridhar CN
    Ann N Y Acad Sci; 1981; 370():708-13. PubMed ID: 6168228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin binding site, conformational change, and activation of antithrombin.
    Evans DL; Marshall CJ; Christey PB; Carrell RW
    Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of heparin with antithrombin III and platelet factor 4: pH dependence demonstrated with a new rocket precipitin Electrophoretic procedure.
    Wohl H; Hinkley J; Krishnan L; Weekly L
    Anal Biochem; 1982 Sep; 125(2):433-41. PubMed ID: 7181101
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of heparin and low molecular weight heparin.
    Nielsen JI; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.